• "It's Only a Model": When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein
• A broad wastewater screening and clinical data surveillance for virus-related diseases in the metropolitan Detroit area in Michigan
• A case of acute kidney injury due to native kidney BK polyomavirus-associated nephropathy in a human T-lymphotropic virus type 1 carrier
• Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer
• Adult T-cell leukemia/lymphoma
• Adult T-cell Leukemia/Lymphoma (ATL) in the Nasal and Paranasal Cavity: Four Cases Report
• Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
• Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy
• Altered apoptosis and proliferation in milk cells and PBMc from BLV-infected bovines with different proviral loads: Possible role of the BCL-2 family proteins, TNF-alpha, and receptors
• An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits
• An immunoinformatics study reveals a new BoLA-DR-restricted CD4+ T cell epitopes on the Gag protein of bovine leukemia virus
• Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma
• Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia/lymphoma
• Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS
• Artificial neural network-based gene screening and immune cell infiltration analysis of osteosarcoma feature
• Association between Brain White Matter Lesions and Disease Activity in HAM/TSP Patients
• Case Report: Disseminated Paracoccidioidomycosis and Strongyloides Hyperinfection in a Patient with Human T-Lymphotropic Virus Type 1/2 Infection
• CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma
• Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers
• Cytokine secretion in stem cells of cattle infected with bovine leukaemia virus
• Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals
• Detection of early phase human T-cell leukemia virus type 1 and 2 infection with an improved confirmatory test
• Determination of molecular epidemiologic pattern of human T-lymphotropic virus type 1 (HTLV-1) in Alborz province, Iran
• Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma
• Effects of bovine leukemia virus seropositivity and proviral load on milk, fat, and protein production of dairy cows
• Epidemiological and molecular evidence of intrafamilial transmission through sexual and vertical routes in Bahia, the state with the highest prevalence of HTLV-1 in Brazil
• Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus
• Evaluating a Retro-Inverso Type Inhibitor of HTLV-1 Protease as a Competitive Inhibitor
• Exploration of semen quality analyzed by casa-mot systems of brahman bulls infected with BLV and BHV-1
• Gene-to-gene coordinated regulation of transcription and alternative splicing by 3D chromatin remodeling upon NF-κB activation
• Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia: Insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and Japan
• How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis
• HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection
• HTLV in Sweden
• HTLV infection in blood donors from Mato Grosso do Sul state: a closer look at HTLV screening in Brazilian blood banks
• HTLV infection in persons with sexually transmitted diseases in Spain
• HTLV-1 as a contributing factor towards scabies and its systemic sequelae
• HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations
• HTLV-1 in Brazil: epidemiological scenario in the highest endemic country in the world
• HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1-associated myelopathy
• HTLV-1 infected T cells cause bone loss via small extracellular vesicles
• HTLV-1 Presenting as an Incidental Finding after a Cosmetic Procedure
• HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
• HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation
• HTLV-1-associated myelopathy in Spain
• Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets
• Human T-cell leukemia virus type 1 uses a specific tRNA(Pro) isodecoder to prime reverse transcription
• Human T-cell Lymphotropic Virus Type-1-associated Bronchioloalveolar Disorder with Non-necrotizing Granulomas: A Case Report and Literature Review
• Human T-lymphotropic virus 1/2 infection among immigrants and refugees in Central Brazil, an emerging vulnerable population
• Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease
• Identification of novel immune infiltration-related biomarkers of sepsis based on bioinformatics analysis
• Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach
• Illuminating HTLV 1-induced Adult T-cell Leukemia/Lymphoma transcriptomic signature: a systems virology approach
• IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells <em>via</em> cereblon through downregulation of target proteins and their downstream effectors
• Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
• Inflammatory progressive multifocal leukoencephalopathy with human T-cell lymphotropic virus-1 coinfection
• Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells via modulation of NF-kappaB, AP-1, and Akt signaling
• Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral Virion
• Low proviral load in the Kumamoto strain of Japanese Brown cattle infected with the bovine leukemia virus
• Making HTLV-1 and those affected visible
• Measures for the Prevention of Mother-to-Child Human T-Cell Leukemia Virus Type 1 Transmission in Japan: The Burdens of HTLV-1-Infected Mothers
• Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
• MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV
• Mining phase separation-related diagnostic biomarkers for endometriosis through WGCNA and multiple machine learning techniques: a retrospective and nomogram study
• Molecular analysis of the env, LTR, and pX regions of bovine leukemia virus in dairy cattle of Türkiye
• Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy
• Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report
• Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities
• Non-cancerous complications in HTLV-1 carriers
• Novel computational and drug design strategies for the inhibition of human T-cell leukemia virus 1-associated lymphoma by Astilbin derivatives
• Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey
• PCBP1 interacts with the HTLV-1 Tax oncoprotein to potentiate NF-kappaB activation
• Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations
• Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia
• Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein
• Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification strategy based on preparation and in-solution digestion methods of total proteins
• Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions
• RAISING revealed a heterogenous pattern of HTLV-1 clonality after HLA-haploidentical peripheral blood stem cell transplantation for ATL
• Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells
• Ripasudil as a Potential Therapeutic Agent in Treating Secondary Glaucoma in HTLV-1-Uveitis: An In Vitro Analysis
• Risk factors associated with enzootic bovine leukosis in Boyacá and Cundinamarca municipalities, Colombia
• Screening for HTLV-1 infection should be expanded in Europe
• Seroprevalence and detection of bovine leukosis virus in semen from breeding bulls in Costa Rica
• Seroprevalence of Human T-Cell Lymphotropic Virus-1 in a Jamaican Antenatal Population and Assessment of Pooled Testing as a Cost Reduction Strategy for Implementation of Routine Antenatal Screening
• Seroprevalence of reproductive and infectious diseases in cattle: the case of Madre de Dios in the Peruvian southeastern tropics
• Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review
• Study of the proviral load levels and mRNA expression of cytokines in peripheral blood mononuclear cells and somatic milk cells in cattle with different BLV infection profiles
• Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
• T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1
• Temporal patterns of bovine leukemia virus infection in dairy herds in Atlantic Canada
• The identification of a PTEN-associated gene signature for the prediction of prognosis and planning of therapeutic strategy in endometrial cancer
• The impact of HTLV-1 expression on the 3D structure and expression of host chromatin
• The importance of confirmatory assays in testing blood donors for human T-cell lymphotropic virus
• The Pleiotropic Effects of YBX1 on HTLV-1 Transcription
• Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review
• Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections
• Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review
• Viral oncogenes, viruses, and cancer: a third-generation sequencing perspective on viral integration into the human genome
• Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses
• YAP suppresses human T-cell leukemia virus type 1 transcription